13.07.2015 Views

Final Facilitator Guide - EngenderHealth

Final Facilitator Guide - EngenderHealth

Final Facilitator Guide - EngenderHealth

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Section 43. Explain that we now know many ways to reduce the risk of HIVbeing transmitted on from a mother to child. Take the participantsthrough Handout ‘A’. The diagrams are designed to share theinformation below in an easy-to-understand format. Refer to thischart while explaining the diagrams in the handout.<strong>Facilitator</strong>’s <strong>Guide</strong>2Adherence to Treatment for HIV4. While showing the handouts, explain the difference between theone pill shown in the first four diagrams (single dose nevirapine),and the group of pills shown in the final diagram (triple ART).Explain that it is recommended thatMost HIV-positive pregnant women receive one dose ofthe drug nevirapine at the onset of labor. The newbornshould also receive a dose of nevirapine 2 to 3 days afterdelivery. However, if a pregnant woman has a CD4 countof 200 or less, then a woman should start ARTimmediately during her pregnancy. Pregnant womenalready on ART should continue their ART regimen. Ifthe woman is on efavirenz, then she will be asked to stoptaking it or change the combination if she is consideringpregnancy.5. The final page of the handout stresses the importance of exclusivebreastfeeding or exclusive bottle-feeding. Explain thatParents may not be able to exclusively bottle-feed, eventhough this reduces the risk of HIV transmission.Ask the group why bottle-feeding may not be possible?58

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!